Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Assets (2019 - 2025)

Historic Return on Assets for 10x Genomics (TXG) over the last 7 years, with Q4 2025 value amounting to 0.04%.

  • 10x Genomics' Return on Assets rose 1500.0% to 0.04% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.04%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.04% for FY2025, which is 1500.0% up from last year.
  • As of Q4 2025, 10x Genomics' Return on Assets stood at 0.04%, which was up 1500.0% from 0.08% recorded in Q3 2025.
  • In the past 5 years, 10x Genomics' Return on Assets ranged from a high of 0.04% in Q4 2025 and a low of 0.57% during Q1 2021
  • Moreover, its 5-year median value for Return on Assets was 0.17% (2023), whereas its average is 0.22%.
  • Within the past 5 years, the most significant YoY rise in 10x Genomics' Return on Assets was 4900bps (2021), while the steepest drop was -4900bps (2021).
  • Over the past 5 years, 10x Genomics' Return on Assets (Quarter) stood at 0.06% in 2021, then plummeted by -183bps to 0.16% in 2022, then plummeted by -63bps to 0.27% in 2023, then grew by 26bps to 0.2% in 2024, then soared by 79bps to 0.04% in 2025.
  • Its Return on Assets was 0.04% in Q4 2025, compared to 0.08% in Q3 2025 and 0.09% in Q2 2025.